Natixis Funds Trust II's Loomis Sayles Strategic Alpha Fund (LABAX) has disclosed 48 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2025-03-31. The current portfolio value is calculated to be $11.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 7%.
Loomis Sayles Strategic Alpha Fund (LABAX)'s
Total Assets is $709.80 Mil , Total Liabilities is $26.12 Mil , Net Assets is $683.68 Mil.
In Loomis Sayles Strategic Alpha Fund (LABAX)'s current portfolio as of 2025-03-31, the top 5 holdings are
Cemex SAB de CV (CX), BioMarin Pharmaceutical Inc (BMRN), Paramount Global (PARA), Altice USA Inc (ATUS) and Merck & Co Inc (MRK),
not including call and put options.
Loomis Sayles Strategic Alpha Fund (LABAX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Loomis Sayles Strategic Alpha Fund (LABAX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Loomis Sayles Strategic Alpha Fund (LABAX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Loomis Sayles Strategic Alpha Fund.